Citation Impact
Citing Papers
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas
2003
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates
2003
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
2013
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Nasopharyngeal carcinoma
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Inflammation and cancer
2002 StandoutNature
Testicular Germ-Cell Cancer
1997 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
2013
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
1995
Carcinoma of the nasopharynx: factors affecting prognosis
1992
Insular thyroid cancer
2012
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach
2007
Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma
2006
Minimal-invasives follikuläres Schilddrüsenkarzinom
2010
Lateral gene transfer and the nature of bacterial innovation
2000 StandoutNature
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
1990
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Molecular mechanisms of drug resistance
2005
The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor
1991
Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomography
1995
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study
2009
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients
2002
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
2005
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.
1998
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials
2001
Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland
2006
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
2002
Angiogenesis in cancer and other diseases
2000 StandoutNature
Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3
2017 StandoutNatureNobel
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns
2004
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
The origin of pattern and polarity in the Drosophila embryo
1992 StandoutNobel
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis
2006
The trk proto-oncogene encodes a receptor for nerve growth factor
1991
Significance, detection and markers of disseminated breast cancer cells
2006
O-GlcNAc cycling: Implications for neurodegenerative disorders
2009
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
2008
Beyond the Suspicious Thyroid Fine Needle Aspirate
2003
Integrative analysis of RUNX1 downstream pathways and target genes
2008
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
Progress in molecular-based management of differentiated thyroid cancer
2013
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
1991
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
1999 StandoutNatureNobel
Cancer vaccines: between the idea and the reality
2003
Hypoxic gene expression and metastasis
2004
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
1994
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma
2011
Hypoxia-driven selection of the metastatic phenotype
2007
Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas
2002
A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5‐fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma
2004
Fusion of a novel gene,ELKS, toRET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma
1999
Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders
2006
Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients
2011
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
2000
The Hallmarks of Aging
2013 Standout
Apoptosis and therapy
1999
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Differentiated Thyroid Cancer: Determinants of Disease Progression in Patients <21 Years of Age at Diagnosis
1998
Molecular genetics and diagnosis of thyroid cancer
2011
Cancer-related inflammation
2008 StandoutNature
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
2003
Radiation-induced thyroid cancer: What we have learned from Chernobyl
2006
Pathogenesis of adult testicular germ cell tumors
1990
Genomic organization and chromosomal mapping of ELKS, a gene rearranged in a papillary thyroid carcinoma
2000
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Lung cancer in never smokers — a different disease
2007
Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours
2002
T-cell responses of vaccinated cancer patients
2003
The cancer genome
2009 StandoutNature
Solid Variant of Papillary Thyroid Carcinoma
2001
Tumors and inflammatory infiltrates: Friends or foes?
2002
Tall-Cell Variant of Papillary Thyroid Carcinoma: A Matched-Pair Analysis of Survival
2010
Lessons from Mouse Models of Thyroid Cancer
2009
Tall Cell Variant of Papillary Thyroid Carcinoma without Extrathyroid Extension: Biologic Behavior and Clinical Implications
2007
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Clinical Features and Prognostic Factors for Survival in Patients with Poorly Differentiated Thyroid Carcinoma and Comparison to the Patients with the Aggressive Variants of Papillary Thyroid Carcinoma
2007
bax -deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
1997
Life with Oxygen
2007 StandoutScienceNobel
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
2002
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
2005
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
1995
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas
1988
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
2003
A family of RIM-binding proteins regulated by alternative splicing: Implications for the genesis of synaptic active zones
2002 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
A General Mechanism for Network-Dosage Compensation in Gene Circuits
2010 StandoutScienceNobel
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.
1991
Evolution of the Management of Stage I Nonseminomatous Germ-cell Tumors of the Testis
1991
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
1997
The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched- related gene, TRC8
1998
Induction by NGF of Meiotic Maturation of Xenopus Oocytes Expressing the trk Proto-Oncogene Product
1991 Science
p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
1998
Viruses in Human Cancers
1991 StandoutScienceNobel
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
Growth Factors and Cancer
1991 StandoutScience
Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma
2000
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
2000
An evidence‐based review of poorly differentiated thyroid cancer
2007
Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.
1991 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm
1991
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion
2010
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
2000
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
2001
The incidence of p53 mutations increases with progression of head and neck cancer.
1993
Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners
2012 StandoutNobel
Accelerated Concomitant Boost Radiotherapy and Chemotherapy for Advanced Nasopharyngeal Carcinoma
2001
Different point mutations in the met oncogene elicit distinct biological properties
2000
Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
2009
Works of S. Pilotti being referenced
Association between cigarette smoking and FHIT gene alterations in lung cancer.
1997
Aberrant FHIT transcripts in Merkel cell carcinoma.
1996
Elevated Risk for MPNST in NF1 Microdeletion Patients
2003
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
2002
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
1994
Overexpression of the C-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium
1995
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
1993
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
1988
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
2008
Extensive vascular invasion is a marker of risk of relapse in encapsulated non‐Hürthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11‐year median follow‐up
2004
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
2006
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
2001
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma.
1996
Loss of heterozygous DNA markers in human germ cell neoplasms
1989
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
1996
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
1992
Prediction of TP53 Status for Primary Cisplatin, Fluorouracil, and Leucovorin Chemotherapy in Ethmoid Sinus Intestinal-Type Adenocarcinoma
2004
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
1992
Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal.
1986
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
1987 Nature
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
1994
Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.
1996
Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?
1995
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas.
1997
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
2012
Adjuvant Chemotherapy in Resected Stage-II NonseminomatousGerm Cell Tumors of Testis
1984
Human Papillomavirus Type 16 DNA in Genital Tumours: A Pathological and Molecular Analysis
1986
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
2000
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.
1997
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
1989